Advertisement
U.S. markets closed

BioSig Technologies, Inc. (BSGM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.7051+0.0191 (+2.78%)
At close: 04:00PM EST
0.7200 +0.01 (+2.11%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close0.6860
Open0.6800
Bid0.6902 x 1800
Ask0.7200 x 800
Day's Range0.6116 - 0.7300
52 Week Range0.2620 - 16.5000
Volume274,453
Avg. Volume319,238
Market Cap6.582M
Beta (5Y Monthly)1.40
PE Ratio (TTM)N/A
EPS (TTM)-4.7000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est55.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BSGM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BioSig Technologies, Inc.
    Analyst Report: Abbott LaboratoriesAbbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
    Rating
    Fair Value
    Economic Moat
    9 days agoMorningstar
View more
  • GlobeNewswire

    BioSig Announces Reduction of its Workforce

    Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a significant number of its employees and expects to substantially reduce business operations. About BioSig Technologies, Inc.BioSig Technologies is a medical technology company. The Company's product, the PURE EP™ Platform, an FDA 510(k) cleared non-invasive class II device, provides superior, real-time sign

  • GlobeNewswire

    BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases

    Company sees clinical adoption and usage of its novel Near Field Tracking algorithm, proven to reduce ablation time by approximately 66%.Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that physicians have completed over 100 cases with the Near Field Tracking (“NFT”) algorithm, an inno

  • GlobeNewswire

    BioSig Announces Reverse Stock Split

    Common Stock Will Begin Trading on Split-Adjusted Basis on February 2, 2024Westport, CT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. The reverse stock split will be